Premium Content
Subscriber only
Men are more susceptible than women to reproductive tract infections from COVID rendering some infertile, new research has found.
Scientists from the Australian and New Zealand Society of Reproductive Endocrinology have combined with the European Society of Human Reproduction and Embryology, the American Society for Reproductive Medicine for the research on the virus’ impacts on fertility.
Their research was presented this week at the 10th Congress of the Asia Pacific Initiative on Reproduction ASPIRE.
Reproductive medicine specialist Associate Professor Virgilio Novero said research had found COVID disrupts the protective role of an enzyme on the surface of many cells.
Saturday, 1 May 2021, 5:57 pm
SINGAPORE, May 1, 2021 /PRNewswire/
A review of
global research of the impact of COVID-19 on human fertility
suggests males are more susceptible than females to
reproductive tract infection from the virus.
A summary
of international studies on the effect of COVID-19 on
fertility was presented today at the 10th Congress of the
Asia Pacific Initiative on Reproduction (ASPIRE). The ASPIRE
Congress, originally to be held in the Philippines, is being
presented in virtual format – https://aspire2021.cme-congresses.com
– to more than 100 countries because of ongoing concerns
about COVID-19.
Associate Professor Virgilio Novero, a
specialist in reproductive medicine at the University of the
Copyright AFP 2017-2021. All rights reserved.
Social media posts claim that people vaccinated against Covid-19 pose a health risk to those who have not been immunized by “shedding” spike proteins. But experts say this is impossible, and that there is also no proof for the claim that the shots affect fertility.
“Stay Away From Them,” says an April 19, 2021 video post on Instagram by a woman who presents herself as a nurse.
Screenshot of an Instagram post taken on April 29, 2021
The video has also been shared on Facebook, Rumble and BitChute.
Similarclaims have been circulating on social media, and a Florida private school barred teachers who have been vaccinated against Covid-19 from coming into contact with students, citing misinformation about the shots as justification.
Fertility Supplements Market Segment Analysis – By Distribution Channel
On the basis of distribution channel, the OTC segment accounted for the largest segmental revenue of the fertility supplements market in 2019 owing to the fact that the easy availability of raw materials, rising demand, and lenient regulations. In order to enter this highly competitive market, the companies need to focus on incorporating ingredients that have been regulated by the FDA and have undergone a significant number of clinical trials/studies.
However, the prescribed segment is poised to hold the highest growth rate with a CAGR of 7.89% over the forecast period 2020-2025. This is attributed to the fact that the manufacturers endorse their products by providing clinical evidence for the ingredients included rather than focusing on the finished product. Hence, companies such as Fairhaven, Lenus Pharma, and Gonadosan, Innovamed Ltd. have provided evidence from the clinical trials of their finished produc